{"id":42592,"date":"2025-08-16T11:39:24","date_gmt":"2025-08-16T11:39:24","guid":{"rendered":"https:\/\/quickassetsmarket.com\/index.php\/2025\/08\/16\/buffetts-1-6-bn-bet-lifts-unitedhealth-to-16-yr-high-but-analysts-urge-caution-before-buying\/"},"modified":"2025-08-16T11:39:24","modified_gmt":"2025-08-16T11:39:24","slug":"buffetts-1-6-bn-bet-lifts-unitedhealth-to-16-yr-high-but-analysts-urge-caution-before-buying","status":"publish","type":"post","link":"https:\/\/quickassetsmarket.com\/index.php\/2025\/08\/16\/buffetts-1-6-bn-bet-lifts-unitedhealth-to-16-yr-high-but-analysts-urge-caution-before-buying\/","title":{"rendered":"Buffett\u2019s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying"},"content":{"rendered":"
<\/div>\n

UnitedHealth Group shares surged more than 11% in Friday trading, on track for their strongest single-day performance since 2009, after a regulatory filing revealed Warren Buffett\u2019s Berkshire Hathaway had quietly built a $1.6 billion position in the health-insurance giant. <\/p>\n

The conglomerate disclosed ownership of 5 million shares at the end of the second quarter, having sought regulatory permission to accumulate the stake in secret beginning late last year to avoid triggering a price spike.<\/p>\n

The rally comes as a welcome reprieve for UnitedHealth, whose shares had more than halved in value<\/a> over the past 12 months amid a series of sharp selloffs. <\/p>\n

Until last week, the stock was trading near its 52-week low of $234.60.<\/p>\n

Berkshire’s UNH purchase comes amid mounting headwinds<\/h2>\n

Berkshire\u2019s purchase stands in contrast to mounting concerns about the company\u2019s fundamentals. <\/p>\n

UnitedHealth has been battered by rising reimbursement costs that have rippled across the healthcare sector, with its insurance division taking a particularly heavy hit. <\/p>\n

The company\u2019s public image also suffered after the December 2024 killing of UnitedHealthcare executive Brian Thompson, an event that drew attention to frustrations with the US health insurance system.<\/p>\n

Adding to the turbulence, the Department of Justice is investigating the company for potential criminal Medicare fraud, following a Wall Street Journal report. <\/p>\n

UnitedHealth confirmed in July it is complying with both criminal and civil requests.<\/p>\n

The political climate has also turned more challenging. <\/p>\n

Both the Trump administration and large pharmaceutical companies have targeted pharmacy-benefit managers, such as UnitedHealth\u2019s Optum Rx, with proposals to cut them out of the drug pricing chain.<\/p>\n

Valuation still rich despite price slide<\/h2>\n

Even after the steep decline, UnitedHealth shares are not trading at a discount. <\/p>\n

The stock\u2019s forward price-to-earnings ratio of 16.45 times is well above the industry average of 12.12. <\/p>\n

Analyst sentiment has cooled rapidly, with five downward revisions to 2025 and 2026 earnings estimates over the past week alone. <\/p>\n

The Zacks Consensus now points to a 36.4% drop in 2025 earnings per share, though revenues are expected to grow by more than 12% year-over-year.<\/p>\n

The company\u2019s removal from the Russell Top 200 Growth, Russell 1000 Growth, and Russell 3000 Growth indices underscores the shift in how investors view the stock\u2014from a dependable growth name to a company struggling with cost inflation and margin compression.<\/p>\n

Operational and regulatory pressures intensify<\/h2>\n

UnitedHealth\u2019s challenges are not limited to earnings misses. <\/p>\n

Rising volumes of high-acuity care, deteriorating Medicare Advantage economics, and higher medical loss ratios are weighing on profitability. <\/p>\n

Molina Healthcare and Centene face similar cost headwinds, but UnitedHealth\u2019s size has made it a high-profile target for regulators.<\/p>\n

The DOJ probe into Medicare billing practices could bring fines or clawbacks. <\/p>\n

Meanwhile, lawmakers are increasing scrutiny on PBMs, with proposals that could upend Optum Rx\u2019s business model. <\/p>\n

The potential regulatory shifts present a risk to long-term earnings visibility.<\/p>\n

Management changes and long-term initiatives<\/h2>\n

In an effort to steady operations<\/a>, UnitedHealth has appointed Wayne DeVeydt\u2014who recently stepped down from Centene\u2019s board\u2014as chief financial officer. <\/p>\n

The company hopes fresh leadership will help navigate its operational and reputational challenges.<\/p>\n

Management has outlined plans to leverage artificial intelligence and digital platforms to streamline costs and improve efficiency. <\/p>\n

Its UnitedHealthcare division reported serving 50.1 million members as of June 30, 2025, a 2.1% increase from a year earlier, driven by growth in self-funded commercial plans. <\/p>\n

Broader industry trends, including an aging population and rising chronic disease prevalence, continue to support long-term demand for healthcare services.<\/p>\n

Dividend growth signals confidence<\/h2>\n

Despite the challenges, UnitedHealth returned $4.5 billion to shareholders in the second quarter through dividends and buybacks. <\/p>\n

In June, the company raised its quarterly dividend by 5%, a move seen as a signal of confidence in its long-term cash flow.<\/p>\n

The company has also indicated that Medicare Advantage rate increases in 2026 could help alleviate margin pressures. <\/p>\n

However, details on how quickly this might translate into earnings growth remain scarce.<\/p>\n

Analysts urge caution despite Berkshire\u2019s vote of confidence<\/h2>\n

While Warren Buffett\u2019s purchase suggests he sees long-term value in UnitedHealth, analysts remain wary. <\/p>\n

Zacks notes that the company\u2019s sharp earnings misses, lowered 2025 guidance, and operating cash flow collapse point to deeper structural problems.<\/p>\n

The firm argues that the stock\u2019s valuation premium to peers like Molina and Centene is difficult to justify given the lack of near-term visibility on a turnaround. <\/p>\n

Until medical cost trends stabilize, regulatory threats subside, and margins recover, analysts say the risks may outweigh the potential rewards for new investors.<\/p>\n

The post Buffett\u2019s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying<\/a> appeared first on Invezz<\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

UnitedHealth Group shares surged more than 11% in Friday trading, on track for their strongest single-day performance since 2009, after a regulatory filing revealed Warren Buffett\u2019s Berkshire Hathaway had quietly built a $1.6 billion position in the health-insurance giant. The conglomerate disclosed ownership of 5 million shares at the end of the second quarter, having <\/p>\n","protected":false},"author":1,"featured_media":42593,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-42592","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"_links":{"self":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/42592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/comments?post=42592"}],"version-history":[{"count":0,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/42592\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media\/42593"}],"wp:attachment":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media?parent=42592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/categories?post=42592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/tags?post=42592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}